HDAC6 is a microtubule-associated deacetylase
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function. The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts. However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC6 catalyzes the deacetylation of K40 in the α-tubulin subunit of the microtubule,24 thereby regulating microtubule dynamics”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [24]
In the citing paper
“HDAC6, a tubulin deacetylase [24].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [24]
In the citing paper
“The histone deacetylase 6 (HDAC6) has also been implicated in tau deacetylation/acetylation [180].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [180]
In the citing paper
“HDAC6 was shown to be the deacetylase for a diverse set of substrates involved in tumourigenesis, such as HSP90, α-tubulin, cortactin and peroxiredoxins”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
In the citing paper
“HDAC6 knockout in mice does not lead to embryonic lethality”
From A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth (2013) · cites this paper as Hubbert et al, 2002
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 1×
“At least 11 proteins predicted to be members of the HDAC family have been identified on the basis of homology within the catalytic domai”
BackgroundPiperno, G., & Fuller, M. T. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.6.2085 · Cited by 757
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T.-P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582
Self-citationMicrotubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation
Kaverina, I., Krylyshkina, O., & Small, J. V. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.1033 · Cited by 480
Histone acetylation: chromatin in action
Wade, P. A., Pruss, D., & Wolffe, A. P. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01016-5 · Cited by 471
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412 · cited 1×
“Unlike other family members, HDAC6 is uniquely resistant to the potent HDAC inhibitors trapoxin-B (TPXb”
BackgroundSelf-citationRegulation of cytoplasmic dynein behaviour and microtubule organization by mammalian Lis1
Smith, D. S., Niethammer, M., Ayala, R., Zhou, Y., Gambello, M. J., Wynshaw-Boris, A., & Tsai, L.-H. (2000) · Nature Cell Biology · doi:10.1038/35041000 · Cited by 381
Cited by
Items 601–700 of 1,012
Piracha, Z. Z., Kwon, H., Saeed, U., Kim, J., Jung, J., Chwae, Y., Park, S., Shin, H., & Kim, K. H. (2018) · Journal of Virology · doi:10.1128/jvi.00955-18 · Cited by 75
“sively cytoplasmic protein (43), it was detected only in the cytoplasmic fraction (Fig.”
BackgroundRetractedSuzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300414 · Cited by 71
HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity
Tsushima, H., Emanuele, M., Polenghi, A., Esposito, A., Vassalli, M., Barberis, A., Difato, F., & Chieregatti, E. (2015) · Nature Communications · doi:10.1038/ncomms8781 · Cited by 71
Role of tubulin acetylation in cellular functions and diseases
Nekooki-Machida, Y., & Hagiwara, H. (2020) · Medical Molecular Morphology · doi:10.1007/s00795-020-00260-8 · Cited by 79
Zhang, H., Du, ., Yang, Q., & Zhu, M. J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.09.020 · Cited by 75
“The limited change ofα-tubulin acetylation in BMMCwas probably due to the function of HDAC6, which is a tubulin-specific deacetylase and is resistant to the inhibition of butyrate [23].”
BackgroundSchneider, B. J., Kalemkerian, G. P., Bradley, D., Smith, D. C., Egorin, M. J., Daignault, S. D., Dunn, R. L., & Hussain, M. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9503-6 · Cited by 74
“Preclinical studies suggest the combination of a taxane and an HDAC inhibitor, such as vorinostat, may be synergistic and result in enhanced tubulin acetylation that facilitates mitotic arrest of cells [ 19 , 45].”
BackgroundThe Tubulin Code: A Navigation System for Chromosomes during Mitosis
Barisic, M., & Maiato, H. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.06.001 · Cited by 71
“Acetylation of lysine 40 of / [7_TD$DIFF]-tubulin occurs on the microtubule lumen and is mediated by the tubulin acetyl transferase /TAT1, whereas deacetylation is performed by at least two deacetylases, HDAC6 and Sirt2.”
BackgroundInfluentialChoi, H., Kim, H. J., Kim, J., Kim, S., Yang, J., Lee, W., Park, Y., Hyeon, S. J., Lee, D.-S., Ryu, H., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0164-1 · Cited by 71
Brijmohan, A. S., Batchu, S. N., Majumder, S., Alghamdi, T. A., Thieme, K., McGaugh, S., Liu, Y., Advani, S. L., Bowskill, B. B., Kabir, M. G., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00034 · Cited by 71
“Treatment of proximal tubule lineage NRK-52E cells with the HDAC6 inhibitor Tubastatin A caused a dosedependent increase in the acetylation of the established HDAC6 substrate α-tubulin (Hubbert et al., 2002) (Figure 3A), indicative of HDAC6 inhibition.”
BackgroundRegional and subcellular distribution of HDAC4 in mouse brain
Darcy, M. J., Calvin, K., Cavnar, K., & Ouimet, C. C. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22241 · Cited by 69
“For example, a role for HDAC6 has been established as the primary deacetylase for tubulin (Hubbert et al., 2002).”
BackgroundATAT1-enriched vesicles promote microtubule acetylation via axonal transport
Even, A., Morelli, G., Broix, L., Scaramuzzino, C., Turchetto, S., Gladwyn-Ng, I., Le Bail, R., Shilian, M., Freeman, S., Magiera, M. M., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax2705 · Cited by 69
“UAS-Syt1:GFP (BDSC 6925), UAS-RNAi Atat1 (VDRC CG3967), UAS-RNAi Atat2 (VDRC CG17003), UAS-RNAi Hdac6 (BDSC 51181), and UAS-RNAi Zpg (VDRC CG10125) were used as control.”
BackgroundInfluentialAttenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6
Cao, Z., Gu, Z., Lin, S., Chen, D., Wang, J., Zhao, Y., Li, Y., Liu, T., Li, Y., Wang, Y., et al. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00681 · Cited by 64
Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review
Mesgari, H., Esmaelian, S., Nasiri, K., Ghasemzadeh, S., Doroudgar, P., & Payandeh, Z. (2023) · Cancers · doi:10.3390/cancers15235600 · Cited by 99
“Furthermore, HDAC6 was found to not only deacetylate histones but also deacetylate α -tubulin, thereby promoting cell motility dependent on microtubules, which is a process that may contribute to metastasis development [371].”
BackgroundMiki, Y., Mori, F., Tanji, K., Kakita, A., Takahashi, H., & Wakabayashi, K. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01200.x · Cited by 70
“Under normal conditions, HDAC6 is localized exclusively in the cytoplasm and, to a lesser extent, in the axons.(20,23) HDAC6 binds to and facilitates the transport of ubiquitinated misfolded proteins through the microtubule network to form aggresomes.”
BackgroundModulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Woan, K. V., Sahakian, E., Sotomayor, E. M., Seto, E., & Villagra, A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.96 · Cited by 69
Valproic acid: how it works. Or not
Lagace, D. C., O'Brien, W. T., Gurvich, N., Nachtigal, M. W., & Klein, P. S. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.09.013 · Cited by 72
Histone deacetylase modulators provided by Mother Nature
Seidel, C., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0283-9 · Cited by 82
“Indeed, HDAC6and SIRT2-mediated deacetylation of a-tubulin promotes microtubule depolymerization and therefore increases microtubule dynamics and cell mobility (Hubbert et al. 2002).”
HDAC6 Regulates Mutant SOD1 Aggregation through Two SMIR Motifs and Tubulin Acetylation
Gal, J., Chen, J., Barnett, K. R., Yang, L., Brumley, E., & Zhu, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431957 · Cited by 70
PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition
Meng, Z., Jia, L.-F., & Gan, Y. (2015) · Oncogene · doi:10.1038/onc.2015.293 · Cited by 74
Li, Z., Zhang, C., Zhang, Y., Chen, L., Chen, B.-D., Li, Q., Zhang, X., & Li, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.025 · Cited by 74
Song, R. Y., Yang, Y., Han, L., Wang, G., Huang, Y. C., Xue, W., Wang, Y., Yao, L., & Zhu, Y. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.10.007 · Cited by 70
TDP‐43 and FUS/TLS: cellular functions and implications for neurodegeneration
Fiesel, F. C., & Kahle, P. J. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08258.x · Cited by 69
Mawatari, T., Ninomiya, I., Inokuchi, M., HARADA, S., Hayashi, H., Oyama, K., Makino, I., Nakagawara, H., Miyashita, T., Tajima, H., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3213 · Cited by 74
Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma
Nakashima, H., Kaufmann, J. K., Wang, P.-Y., Nguyen, T., Speranza, M. C., Kasai, K., Okemoto, K., Otsuki, A., Nakano, I., Fernández, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80713 · Cited by 74
Piaz, F. D., Tosco, A., Eletto, D., Piccinelli, A. L., Moltedo, O., Franceschelli, S., Sbardella, G., Remondelli, P., Rastrelli, L., Vesci, L., et al. (2010) · ChemBioChem · doi:10.1002/cbic.200900721 · Cited by 72
Hsieh, T., Tsai, C., Hsu, C., Kuo, P., Lee, J.-N., Chai, C., Hou, M., Chang, C., Long, C., Ko, Y., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs163 · Cited by 71
“Particularly, we focused on the role of histone deacetylase 6 (HDAC6), a microtubule-associated deacetylase, which has been shown to regulate the cytoskeleton (Hubbert et al., 2002; Valenzuela-Fernandez et al., 2008) and may play an important role in EMT and cell motility (Fernandez and Russo, 2010).”
BackgroundFerreira de Freitas, R., Harding, R. J., Franzoni, I., Ravichandran, M., Mann, M. K., Ouyang, H., Lautens, M., Santhakumar, V., Arrowsmith, C. H., & Schapira, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00258 · Cited by 64
Li, C., Zeng, Q., Chen, M., Xu, L., Zhang, C., Mai, F., Zeng, C., He, X., & Ouyang, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00290 · Cited by 73
“α-Tubulin in microtubules can be acetylated by α-tubulin N-acetyltransferase (αTAT1/MEC-17), and deacetylated by NAD-dependent α-tubulin deacetylase sirtuin 2 (SIRT2) or histone deacetylase 6 (HDAC6) (Hubbert et al., 2002; Akella et al., 2010; Kalebic et al., 2013), though HDAC6 is not involved in NLRP3 inflammasome a…”
BackgroundHe, S., Dong, G., Wu, S., Fang, K., Miao, Z., Wang, W., & Sheng, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00664 · Cited by 66
Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
Pant, K., Peixoto, E., Richard, S., & Gradilone, S. A. (2020) · Cells · doi:10.3390/cells9030780 · Cited by 76
“In addition, high expression of HDAC3 and HDAC6 was observed in CCA patients’ tissues, linked to low survival [27,28,48].”
BackgroundClinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
Iwamoto, M., Friedman, E. J., Sandhu, P., Agrawal, N. G. B., Rubin, E. H., & Wagner, J. A. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2220-z · Cited by 70
The aggresome pathway as a target for therapy in hematologic malignancies
Simms-Waldrip, T. R., Rodríguez-González, A., Lin, T. L., Ikeda, A. K., Fu, C. H., & Sakamoto, K. M. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.03.012 · Cited by 78
“The C-terminal domain is able to deacetylate α-tubulin both in vitro and in vivo, and this activity is reversibly inhibited by trichosatin A (TSA) [22,23].”
BackgroundClass II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29
Mannaerts, I., Eysackers, N., Onyema, O. O., Van Beneden, K., Valente, S., Mai, A., Odenthal, M., & van Grunsven, L. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055786 · Cited by 68
“The class IIb HDAC6 displays distinct functionality, as its inhibition stimulates tubulin acetylation and influences cell motility [20,21,22].”
BackgroundDerbyshire, P., Ménard, D., Green, P., Saalbach, G., Buschmann, H., Lloyd, C. W., & Pesquet, E. (2015) · The Plant Cell · doi:10.1105/tpc.15.00314 · Cited by 80
“, 2008), and histone deacetylases (Hubbert et al., 2002; Cho and Cavalli, 2012).”
Therapeutic effects of histone deacetylase inhibitors in a murine asthma model
Ren, Y., Su, X., Kong, L., Li, M., Zhao, X., Yu, N., & Kang, J. (2016) · Inflammation Research · doi:10.1007/s00011-016-0984-4 · Cited by 68
Esteves, A. R., Arduíno, D. M., Silva, D. F., Viana, S., Pereira, F. C., & Cardoso, S. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0420-y · Cited by 69
Huang, M., Huang, J., Zheng, Y., & Sun, Q. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.078 · Cited by 67
Azuma, K., Urano, T., Horie‐Inoue, K., Hayashi, S., Sakai, R., Ouchi, Y., & Inoue, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3458 · Cited by 71
“Recently, HDAC6, a class IIB zinc-dependent HDAC predominantly localized in the cytoplasm, has been shown to deacetylate tubulin (7).”
BackgroundTargeting breast cancer stem cells by novel HDAC3-selective inhibitors
Hsieh, H.-Y., Chuang, H.-C., Shen, F.-H., Detroja, K., Hsin, L.-W., & Chen, C.-S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.069 · Cited by 67
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Yue, L., Sharma, V., Horvat, N. P., Akuffo, A. A., Beatty, M. S., Murdun, C., Colin, C., Billington, J. M. R., Goodheart, W. E., Sahakian, E., et al. (2020) · Blood · doi:10.1182/blood.2019895326 · Cited by 67
Van Helleputte, L., Kater, M., Cook, D. P., Eykens, C., Rossaert, E., Haeck, W., Jaspers, T., Geens, N., Vanden Berghe, P., Gysemans, C., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.11.011 · Cited by 66
“These unique features allow HDAC6 to interact with substrates other than histones, including α-tubulin (Hubbert et al., 2002; Zhang et al., 2003).”
A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
Kaliszczak, M., Trousil, S., Åberg, O., Perumal, M., Nguyen, Q.-D., & Aboagye, E. O. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.576 · Cited by 66
“Acelylation of a-tubulin, which promotes microtubule stabilisation, may distort mitosis and trigger apoptosis (Matsuyama et al, 2002); it can also affect changes in cell motility and, hence, invasion and metastasis of cancer cells (Hubbert et al, 2002).”
BackgroundSystemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy
Verheyen, A., Peeraer, E., Nuydens, R., Dhondt, J., Poesen, K., Pintelon, I., Daniels, A., Timmermans, J., Meert, T. F., Carmeliet, P., et al. (2012) · Brain · doi:10.1093/brain/aws145 · Cited by 66
“VEGF stimulation and Flk1 overexpression both decreased acetylated -tubulin levels after paclitaxel exposure, thereby suggesting that histone deacetylase 6 (HDAC6; Hubbert et al., 2002), which is responsible for deacetylation of -tubulin, is involved in mediating these effects.”
BackgroundDour, C. L., Chatzifrangkeskou, M., Macquart, C., Magiera, M. M., Peccate, C., Jouve, C., Virtanen, L., Heliö, T. M., Aalto‐Setälä, K., Crasto, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35639-x · Cited by 75
Zhang, L., Liu, S., Liu, N., Zhang, Y., Liu, M., Li, D., Seto, E., Yao, T., Shui, W., & Zhou, J. (2014) · Protein & Cell · doi:10.1007/s13238-014-0102-8 · Cited by 68
“Previous studies havedocumented several proteins as the substrates of HDAC6, including α-tubulin (Hubbert et al., 2002; Zhang et al., 2003), Hsp90 (Kovacs et al., 2005), cortactin (Zhang et al., 2007), peroxiredoxins (Parmigiani et al., 2008), β-catenin (Li et al., 2008), Ku70 (Subramanian et al.,…”
BackgroundInfluentialSelf-citationAlinsug, M. V., Chen, F. F., Luo, M., Tai, R., Jiang, L., & Wu, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030846 · Cited by 73
“Although most of these Class II HDACs remain inactive in the cytoplasm, HDAC7 and HDAC6 continue to play versatile roles such as mitochondrial proteins implicated in apoptosis, SUMO E3 ligases, and target several cytosolic substrates such as tubulin, cortactin, Hsp90, b- catenin, and peroxiredoxin [27–38].”
BackgroundDifferential protein acetylation induced by novel histone deacetylase inhibitors
Glaser, K. B., Li, J., Pease, L. J., Staver, M. J., Marcotte, P. A., Guo, J., Frey, R. R., Garland, R. B., Heyman, H. R., Wada, C. K., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.082 · Cited by 71
Parker, S. S., Krantz, J. L., Kwak, E., Barker, N. K., Deer, C. G., Lee, N. Y., Mouneimne, G., & Langlais, P. R. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001450 · Cited by 76
Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
Palijan, A., Fernandes, I., Bastien, Y., Tang, L., Verway, M., Kourelis, M., Tavera-Mendoza, L. E., Li, Z., Bourdeau, V., Mader, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045526 · Cited by 65
Store-Operated Ca2+ Entry in Tumor Progression: From Molecular Mechanisms to Clinical Implications
Chen, Y., Lin, P., Yeh, Y., Chen, L.-H., & Shen, M.-R. (2019) · Cancers · doi:10.3390/cancers11070899 · Cited by 71
“HDAC6—a unique cytosol-localized HDAC member—is known as a prominent α-tubulin deacetylase [153].”
BackgroundColeman, A. K., Joca, H. C., Shi, G., Lederer, W. J., & Ward, C. W. (2021) · Journal of General Physiology · doi:10.1085/jgp.202012743 · Cited by 65
African swine fever virus-cell interactions: From virus entry to cell survival
Alonso, C., Galindo, I., Cuesta-Geijo, M. Á., Cabezas, M., Hernáez, B., & Muñoz-Moreno, R. (2012) · Virus Research · doi:10.1016/j.virusres.2012.12.006 · Cited by 75
Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels
Skoge, R. H., Dölle, C., & Ziegler, M. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.04.011 · Cited by 74
Rhee, S. G., & Woo, H. A. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.028 · Cited by 71
Warren, J. C., Rutkowski, A., & Cassimeris, L. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-09-0850 · Cited by 71
“HDAC6 is required for aggresome formation and MT-dependent retrograde transport of misfolded proteins to aggresomes (Kawaguchi et al., 2003).”
BackgroundInfluentialBackstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β
Jiménez‐Uribe, A. P., Gómez‐Sierra, T., Aparicio‐Trejo, O. E., Orozco‐Ibarra, M., & Pedraza‐Chaverrí, J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110123 · Cited by 73
JONES, P. G., Bottomley, M. J., Carfí, A., Cecchetti, O., Ferrigno, F., Surdo, P. L., Ontoria, J. M., Rowley, M., Scarpelli, R., Schultz‐Fademrecht, C., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.026 · Cited by 69
Hdac6 regulates Tip60-p400 function in stem cells
Chen, P. B., Hung, J.-H., Hickman, T. L., Coles, A. H., Carey, J. F., Weng, Z., Chu, F., & Fazzio, T. G. (2013) · eLife · doi:10.7554/elife.01557 · Cited by 63
“, 2008), as are its well-established substrates: α-tubulin (Hubbert et al., 2002), Hsp90 (Kovacs et al.”
BackgroundInfluentialHDAC inhibitors in kidney development and disease
Brilli, L. L., Swanhart, L. M., de Caestecker, M. P., & Hukriede, N. A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2320-8 · Cited by 66
Histone deacetylase inhibitors that target tubulin
Schemies, J., Sippl, W., & Jung, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.040 · Cited by 68
“Paclitaxel functions as a cytostatic by stabilizing microtubules which is dependent also on atubulin acetylation [8,40,41].”
BackgroundBlockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury
Tang, J., Shi, Y., Liu, N., Xu, L., Zang, X., Pei-bin, L., Zhang, J., Zheng, X., Qiu, A., & Zhuang, S. (2018) · Clinical Science · doi:10.1042/cs20171417 · Cited by 66
Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6
Porter, N. J., Wagner, F. F., & Christianson, D. W. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00367 · Cited by 64
Histone modifications as a platform for cancer therapy
Espino, P. S., Drobic, B., Dunn, K. L., & Davie, J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20387 · Cited by 73
“HDACs are also responsible for removing acetyl groups from various other proteins including MyoD, p53, Hsp90, GATA-1, and tubulin [Juan et al., 2000; Hubbert et al., 2002; De Ruijter et al., 2003;Marks et al., 2003].”
BackgroundChen, J., Shi, X., Padmanabhan, R., Wang, Q., Wu, Z., Stevenson, S. C., Hild, M., Garza, D., & Li, H. (2007) · Genome Research · doi:10.1101/gr.6940108 · Cited by 71
HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice
Picci, C., Wong, V. S. C., Costa, C. J., McKinnon, M. C., Goldberg, D. C., Swift, M. L., Alam, N. M., Prusky, G. T., Shen, S., Kozikowski, A. P., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113281 · Cited by 68
Zhang, X., Guo, N., Jin, H., Liu, R., Zhang, Z., Cheng, C., Fan, Z., Zhang, G., Xiao, M., Wu, S., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127911 · Cited by 66
Dallavalle, S., Cincinelli, R., Nannei, R., Merlini, L., Morini, G., Penco, S., Pisano, C., Vesci, L., Barbarino, M., & Zuco, V. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.11.005 · Cited by 65
Fan, L. X., Li, X., Magenheimer, B. S., Calvet, J. P., & Li, X. (2011) · Kidney International · doi:10.1038/ki.2011.296 · Cited by 64
Knock Down of Heat Shock Protein 27 (HspB1) Induces Degradation of Several Putative Client Proteins
Gibert, B., Eckel, B., Fasquelle, L., Moulin, M., Bouhallier, F., Gonin, V., Mellier, G., Simon, S., Kretz‐Remy, C., Arrigo, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029719 · Cited by 69
“This observation prompted us to analyze histone deacetylase 6 (HDAC6), the mammalian enzyme responsible of atubulin deacetylation [31].”
BackgroundMethodXu, X., Kozikowski, A. P., & Pozzo-Miller, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00068 · Cited by 62
“BDNF-YFP TRAFFICKING IN MECP2 KNOCKOUT NEURONS HDAC6 removes acetyl groups from α-tubulin (Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et al., 2003), which makes microtubules less stable.”
BackgroundMacrophages control innate inflammation
Akira, S., Misawa, T., Satoh, T., & Saitoh, T. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12151 · Cited by 62
“We next examined the role of two major α-tubulin deacetylases, SIRT2 and histone deacetylase 6 (HDAC6) [19,20].”
BackgroundChan, K. C., Ting, C. M., Chan, P. S., Lo, M. C., Lo, K. W., Curry, J. E., Smyth, T., Lee, A. W. M., Ng, W. T., Tsao, G. S., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-128 · Cited by 64
“HDAC6, also a client protein of Hsp90 [29], is a key modulator involved in the regulation of cell migration through the deacetylation of tubulins in the cytoplasm [28,30,49].”
BackgroundLee, S. J., & Langhans, S. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-44 · Cited by 62
“HDAC6 can associate with microtubules and deacetylate a-tubulin [33].”
Li, D., Sun, X., Zhang, L., Yan, B., Xie, S., Liu, R., Liu, M., & Zhou, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-0010-3 · Cited by 68
“…to participate in a wide range of cellular processes primarily through its deacetylation of α-tubulin, the actin-binding protein cortactin, and the molecular chaperone heat shock protein 90 (Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et al., 2003; Kovacs et al., 2005; Zhang et al., 2007).”
BackgroundAltered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes
Delépine, C., Méziane, H., Nectoux, J., Opitz, M., Smith, A. B., Ballatore, C., Saillour, Y., Griscelli, A. B., Chang, Q., Williams, E. C., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv464 · Cited by 70
Erburu, M., Muñoz-Cobo, I., Diaz-Perdigon, T., Mellini, P., Suzuki, T., Puerta, E., & Tordera, R. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.033 · Cited by 61
“In the cytoplasm, both the histone deacetylases SIRT2 and the NADþ-independent class II HDAC6 play an important role in regulating microtubule dynamics through deacetylation of a-tubulin on lysine 40 (North et al., 2003; Hubbert et al., 2002).”
Targeted inhibition of histone deacetylase 6 in inflammatory diseases
Ran, J., & Zhou, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12974 · Cited by 64
Yin, H., Ju, Z., Zheng, M., Zhang, X., Zuo, W., Wang, Y., Ding, X., Zhang, X., Peng, Y., Li, J., et al. (2023) · PLOS Biology · doi:10.1371/journal.pbio.3002017 · Cited by 62
“α-Tubulin acetylation has been shown to contribute to cell migration, facilitating fibroblast, and neuronal motility [32,40,41].”
BackgroundInterplay between histone deacetylases and autophagy ‐ from cancer therapy to neurodegeneration
Trüe, O., & Matthias, P. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.103 · Cited by 63
Elongator – an emerging role in neurological disorders
Nguyen, L., Humbert, S., Saudou, F., & Chariot, A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.11.002 · Cited by 69
Ontoria, J. M., Altamura, S., Di Marco, A., Ferrigno, F., Laufer, R., Muraglia, E., Palumbi, M. C., Rowley, M., Scarpelli, R., Schultz-Fademrecht, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900555u · Cited by 61
Seidel, C., Schnekenburger, M., Mazumder, A., Teiten, M.-H., Kirsch, G., Dicato, M. A., & Diederich, M. F. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.005 · Cited by 62
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Tang, G., Wong, J. C., Zhang, W., Wang, Z., Zhang, N., Peng, Z., Zhang, Z., Rong, Y., Li, S., Zhang, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008962 · Cited by 60
Mobley, R. J., Raghu, D., Duke, L. D., Abell-Hart, K., Zawistowski, J. S., Lutz, K., Gomez, S. M., Roy, S., Homayouni, R., Johnson, G. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.030 · Cited by 62
“α-tubulin can be deacetylated by both HDAC6 and SIRT2 (Hubbert et al., 2002; North et al., 2003).”
BackgroundInfluentialKrusche, C., Vloet, A. J., Classen-Linke, I., von Rango, U., Beier, H. M., & Alfer, J. (2007) · Human Reproduction · doi:10.1093/humrep/dem241 · Cited by 65
“the tumor suppressor protein p53 and a-tubulin (Hubbert et al., 2002; Langley et al., 2002; Glozak et al., 2005).”
BackgroundHDAC6 Deacetylase Activity Is Critical for Lipopolysaccharide-Induced Activation of Macrophages
Yan, B., Xie, S., Liu, Z., Ran, J., Li, Y., Wang, J., Yang, Y., Zhou, J., Li, D., & Liu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110718 · Cited by 60
“Histone deacetylase 6 (HDAC6), a unique member of the HDAC family, resides predominantly in the cytoplasm and regulates cytoskeletal dynamics through deacetylation of a-tubulin and cortactin [15,16].”
BackgroundCharacterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
Auzmendi-Iriarte, J., Saenz‐Antoñanzas, A., Mikelez-Alonso, I., Carrasco‐García, E., Tellaetxe-Abete, M., Lawrie, C. H., Samprón, N., Cortajarena, A. L., & Matheu, A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2586-x · Cited by 62
Lysine deacetylases and mitochondrial dynamics in neurodegeneration
Guedes-Dias, P., & Oliveira, J. M. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.005 · Cited by 64
“Conversely, two KDACs, specifically HDAC6 and SIRT2, were found to interact and deacetylate α-tubulin in vitro and in vivo [141–143] (Fig.”
BackgroundPai, M., Tzeng, S., Kovacs, J. J., Keaton, M., Li, S. S. ‐., Yao, T., & Zhou, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.015 · Cited by 62
Self-citationYu, J., Ma, Z., Shetty, S., Ma, M., & Fu, J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00051.2016 · Cited by 62
“Interestingly, -tubulin and -catenin are endogenous substrates of HDAC6 (5, 21, 22, 27, 30).”
BackgroundSong, Y. W., Lim, Y., & Cho, S. K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.003 · Cited by 68
Cognitive impairment in a rat model of neuropathic pain: role of hippocampal microtubule stability
You, Z., Zhang, S., Shen, S., Yang, J., Ding, W., Yang, L., Lim, G., Doheny, J. T., Tate, S., Chen, L. L., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001233 · Cited by 67
“The major enzymes involved in a-tubulin acetylation and deacetylation are a-tubulin acetyltransferase ATAT1 andHDAC6, respectively.(24) We examined both ATAT1 and HDAC6 protein expression in the hippocampus of sham and SNI rats.”
InfluentialRevisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Giannopoulou, A. F., Velentzas, A. D., Konstantakou, E. G., Avgeris, M., Katarachia, S. A., Papandreou, N. C., Kalavros, N., Mpakou, V., Iconomidou, V. A., Anastasiadou, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061291 · Cited by 65
2-Cys Peroxiredoxins: Emerging Hubs Determining Redox Dependency of Mammalian Signaling Networks
Park, J., Lee, S., Lee, S., & Kang, S. W. (2014) · International Journal of Cell Biology · doi:10.1155/2014/715867 · Cited by 64
“Since the microtubule-associated HDAC6 and mitochondrial Sirt3 were discovered [44–46], the reversible acetylation has been considered to be a general modification involved in the cellular signaling.”
BackgroundHDAC2 regulates chromatin plasticity and enhances DNA vulnerability
Marchion, D. C., Bicaku, E., Turner, J. G., Schmitt, M. L., Morelli, D. R., & Munster, P. N. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0985 · Cited by 60
“HDAC6 has been associated with cytoskeletal regulation (45) and may be required for the autophagic response (46).”
BackgroundRNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing
Khan, D. H., Gonzalez, C., Cooper, C., Sun, J.-M., Chen, H. Y., Healy, S., Xu, W. W., Smith, K. T., Workman, J. L., Leygue, E., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1134 · Cited by 71
Ehnert, S., Sreekumar, V., Aspera-Werz, R. H., Sajadian, S. O., Wintermeyer, E., Sandmann, G. H., Bahrs, C., Hengstler, J. G., Godoy, P., & Nussler, A. K. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1526-4 · Cited by 59
Epigenetic Mechanisms in AML – A Target for Therapy
Oki, Y., & Issa, J. J. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_2 · Cited by 68
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Vogelmann, A., Robaa, D., Sippl, W., & Jung, M. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.01.010 · Cited by 58
HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions
Osseni, A., Ravel‐Chapuis, A., Thomas, J.-L., Gache, V., Schaeffer, L., & Jasmin, B. J. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201901099 · Cited by 62
Metadata
- Authors
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P.
- Affiliations
- Duke University (US)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Yao, Tso-Pang
- Venue
- Nature
- Published
- 2002-05
- Volume
- 417
- Issue
- 6887
- Pages
- 455-458
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2064959533
- Cited by
- 2,403
- References
- 21
- Citations by year
- 2026: 96 · 2025: 116 · 2024: 116 · 2023: 126 · 2022: 117 · 2021: 139 · 2020: 130 · 2019: 122 · 2018: 112 · 2017: 102 · 2016: 102 · 2015: 117 · 2014: 119 · 2013: 117 · 2012: 122
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Defense
- Damon Runyon Cancer Research Foundation
- World Bank Group
- Robert Bosch Stiftung
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- HDAC6, alpha-tubulin acetylation, microtubule stability, p150Glued, cell motility, chemotaxis, histone deacetylase
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Chemotaxis, Histone Deacetylases, Microtubule-Associated Proteins, Microtubules, Protein Binding, Tubulin, 3T3 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.